Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

NEW ORLEANS (WVUE) - If you have trouble affording prescription drugs, some independent pharmacists say that so-called ...

CVS expects elevated medical costs to continue to pressure its performance this year, “and as a result we are not providing a ...

In September, the Federal Trade Commission took aim at big pharmacy benefits managers, including CVS subsidiary Caremark, accusing them of inflating insulin prices. “We are not surprised by the ...

CVS Health is one of three pharmacy benefit managers targeted in a lawsuit from the Federal Trade Commission, which has accused the companies of driving up the price of insulin. The three firms ...

In a lawsuit filed last month against CVS Caremark and two other pharmacy benefit managers, the agency said the companies negotiated discounts on insulin but then kept the rebates for themselves ...

CVS Health reported mixed third-quarter results ... FTC sues drug middlemen for allegedly inflating insulin prices Pfizer says drug for deadly cancer condition that causes weight loss shows ...

The Caremark pharmacy benefits management business that Joyner led is under scrutiny from the Federal Trade Commission, which alleged CVS and its rivals drove up insulin prices. Congress is ...